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EXTENDED ABSTRACT 
Biclustering has emerged as an important problem in the analysis of gene expression data since genes may 
only jointly respond over a subset of conditions.  Many of the methods for biclustering, and clustering 
algorithms in general, utilize simplified models or heuristic strategies for identifying the ``best'' grouping of 
elements according to some metric and cluster definition and thus result in suboptimal clusters.   
In the first part of the presentation, we present a rigorous approach to biclustering, OREO, which is based on 
the Optimal RE-Ordering of the rows and columns of a data matrix so as to globally minimize the 
dissimilarity metric [1,2]. The physical permutations of the rows and columns of the data matrix can be 
modeled as either a network flow problem or a traveling salesman problem.  The performance of OREO is 
tested on several important data matrices arising in systems biology to validate the ability of the proposed 
method and compare it to existing biclustering and clustering methods. 
In the second part of the talk, we will focus on novel methods for clustering of data matrices that are very 
sparse [3].  These types of data matrices arise in drug discovery where the x- and y-axis of a data matrix can 
correspond to different functional groups for two distinct substituent sites on a molecular scaffold. Each 
possible x and y pair corresponds to a single molecule which can be synthesized and tested for a certain 
property, such as percent inhibition of a protein function. For even moderate size matrices, synthesizing and 
testing a small fraction of the molecules is labor intensive and not economically feasible. Thus, it is of 
paramount importance to have a reliable method for guiding the synthesis process to select molecules that 
have a high probability of success. In the second part of the presentation, we introduce a new strategy to 
enable efficient substituent reordering and descriptor-free property estimation.  Our approach casts 
substituent reordering as a special high-dimensional rearrangement clustering problem, eliminating the need 
for functional approximation and enhancing computational efficiency [4, 5]. Deterministic optimization 
approaches based on mixed-integer linear programming can provide guaranteed convergence to the optimal 
substituent ordering. The proposed approach is demonstrated on a sparse data matrix (about 29% dense) of 
inhibition values for 14,043 unknown compounds provided by Pfizer Inc. It is shown that an iterative 
synthesis strategy is able to uncover a significant percentage of the lead molecules while using only a 
fraction of total compound library, even when starting from a mere 3\% of the total library space. In the third 
part of the presentation, we combine the strengths of integer linear optimization and machine learning to 
predict in vivo toxicities for a library of pesticide chemicals using only in vitro data. Our approach utilizes a 
biclustering method based on iterative optimal re-ordering [1,2] to identify biclusters corresponding to 
subsets of chemicals that have similar responses over distinct subsets of the in vitro assays. This enables us 
to determine subsets of experimental assays that are most likely to be correlated with toxicity, according to 
the in vivo data set. An optimal method based on integer linear optimization (ILP) for re-ordering sparse 
data matrices [3] is also applied to the in vivo dataset (21.3% sparse) in order to cluster endpoints that have 
similar lowest effect level (LEL) values, where it is observed that endpoints are grouped according to similar 
physiological attributes. Based upon the clustering results of the in vitro and in vivo data sets, logistic 
regression is then utilized to (a) learn the correlation between the subsets of in vitro data and the in vivo 
responses, and (b) subsequently predict the toxicity signatures of the chemicals. Our approach aims to find 
the highest prediction accuracy using the minimum number of in vitro descriptors. 
